139 related articles for article (PubMed ID: 23049073)
1. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.
Kurelac I; MacKay A; Lambros MB; Di Cesare E; Cenacchi G; Ceccarelli C; Morra I; Melcarne A; Morandi L; Calabrese FM; Attimonelli M; Tallini G; Reis-Filho JS; Gasparre G
Hum Mol Genet; 2013 Jan; 22(2):226-38. PubMed ID: 23049073
[TBL] [Abstract][Full Text] [Related]
2. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
4. An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.
Gasparre G; Iommarini L; Porcelli AM; Lang M; Ferri GG; Kurelac I; Zuntini R; Mariani E; Pennisi LF; Pasquini E; Pasquinelli G; Ghelli A; Bonora E; Ceccarelli C; Rugolo M; Salfi N; Romeo G; Carelli V
Hum Mutat; 2009 Mar; 30(3):391-6. PubMed ID: 19086058
[TBL] [Abstract][Full Text] [Related]
5. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
[TBL] [Abstract][Full Text] [Related]
6. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
10. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
11. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C
Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467
[TBL] [Abstract][Full Text] [Related]
12. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
Pereira L; Soares P; Máximo V; Samuels DC
BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
[TBL] [Abstract][Full Text] [Related]
13. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers.
Tan DJ; Chang J; Chen WL; Agress LJ; Yeh KT; Wang B; Wong LJ
Genes Chromosomes Cancer; 2003 Jun; 37(2):186-94. PubMed ID: 12696067
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.
Németh K; Darvasi O; Likó I; Szücs N; Czirják S; Reiniger L; Szabó B; Kurucz PA; Krokker L; Igaz P; Patócs A; Butz H
J Endocrinol Invest; 2019 Aug; 42(8):931-940. PubMed ID: 30684245
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome.
De Luise M; Iommarini L; Marchio L; Tedesco G; Coadă CA; Repaci A; Turchetti D; Tardio ML; Salfi N; Pagotto U; Kurelac I; Porcelli AM; Gasparre G
Cells; 2021 Oct; 10(11):. PubMed ID: 34831144
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial genome instability in colorectal adenoma and adenocarcinoma.
de Araujo LF; Fonseca AS; Muys BR; Plaça JR; Bueno RB; Lorenzi JC; Santos AR; Molfetta GA; Zanette DL; Souza JE; Valente V; Silva WA
Tumour Biol; 2015 Nov; 36(11):8869-79. PubMed ID: 26069104
[TBL] [Abstract][Full Text] [Related]
17. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y
Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the MEN1 gene in sporadic pituitary adenomas.
Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
[TBL] [Abstract][Full Text] [Related]
19. The role of genetic and epigenetic changes in pituitary tumorigenesis.
Fukuoka H; Takahashi Y
Neurol Med Chir (Tokyo); 2014; 54(12):943-57. PubMed ID: 25446387
[TBL] [Abstract][Full Text] [Related]
20. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
